Fanconi anemia (FA) cells are hypersensitive to cytotoxicity, cell cycle arrest, and chromosomal aberrations induced by DNA cross-linking agents, such as mitomycin C ("C) and nitrogen mustard (HN2). Although MMC hypersensitivity is complemented in a subset of FA cells (complementation group C [FA-Cl) by wild-type FAC cDNA, the cytoprotective mechanism is unknown. In the current study, we tested the hypothesis that FAC protein functions in the suppression of DNA interstrand cross-link (ISCI-induced cell cycle arrest and apoptosis. Comparison of HN2-induced cell cycle arrest and apoptosis with those of its non-cross-linking analogs, diethylaminoethyl chloride and 2-dimethylaminoethyl chloride, ANCON1 ANEMIA (FA) is an autosomal-recessive disorder that is characterized by progressive pancytopenia, a predisposition to leukemia, and congenital abnormalities."' A hallmark of FA cells is their selective hypersensitivity to the clastogenic and cytotoxic effects of clinically used DNA cross-linking agents, such as nitrogen mustard (HN2), mitomycin C ("C), and ~isplatin.~-' FA cells are not hypersensitive to monofunctional alkylating agents, UV and ionizing radiation, or the radiomimetic b l e~m y c i n .~,~ The hypersensitivity to cytotoxicity and clastogenesis induced by DNA cross-linkers currently is used as a criterion for diagnosis of Bifunctional alkylating agents preferentially alkylate the N7 position of guanine, producing monoadducts and both intrastrand and interstrand cross-links (ISCs) within The DNA ISC is considered to be the major cytotoxic, clastogenic, and sister chromatid exchange-inducing lesion produced by these agents.17-'I The bis(2-(guanin-7yl)-ethyl) methylamine DNA diadducts represent approximately 25% of lesions produced by HN2." In addition, Osborne et al" have recently reported that HN2 produces N-(2-(3-adeninyl) ethyl)-N-(2-(7-guaninyl) ethyl) methylamine DNA diadducts. Formation of DNA ISCs produced by HN2 correlates with inhibition of DNA replication, reduced RNA transcrip- 
In addition to its potential function in DNA repair, the FAC protein appears to be required for the differentiation of hematopoietic cell^.^' Because inactivation of FAC mRNA with antisense oligonucleotides appears to prevent human myeloid and erythroid cell differentiation, Segal et a14' suggested that FAC suppresses a pathway that leads to apoptosis or that inhibits mitosis in hematopoietic progenitor cells. In addition, M07e cells deprived of granulocyte-macrophage colony-stimulating factor (GM-CSF) undergo apoptosis, and treatment of these cells with antisense oligonucleotides to FAC mRNA accelerates this HSC536N cells contain a T to C transition that leads to a leucine to proline substitution at amino acid position 554 in the FAC pr~tein.'~ This mutation renders cells seven to 20 times more sensitive than wild-type cells to MMC-and diepoxybutane-induced cytotoxicity, and overexpression of the wild-type FAC protein corrects this hypersen~itivity.'~ It is currently unknown whether the cytoprotective effect of FAC complementation is due to suppression of apoptosis ptosis, 19 and whether such a process is ISC-specific. Therefore, we have evaluated the cytoprotective effect of FAC complementation by comparing growth inhibition, cell cycle arrest, and apoptosis induced by HN2 with the perturbations produced by non-cross-linking congeners of HN2, 2-diethylaminoethyl chloride (DEM), and 2-dimethylaminoethyl chloride (DMM). All three agents are similar in that they produce predominately N7-alkyl guanine monoadducts in DNA." In contrast to HN2, DMM and DEM cannot produce DNA ISCs because they lack a second alkylating chloroethyl moiety." The comparison of the cytotoxic effects of HN2 with those of its closely related analogs delineated the lesional specificity of FAC-mediated cytoprotection and suggested that the FAC protein protects against HN2 cytotoxicity by preventing ISC-induced apoptosis.
MATERIALS AND METHODS

Drugs.
HN2 was purchased from Sigma Chemical (St Louis, MO). A stock solution of 50 mmoyL HN2 was prepared in 0.1 N HCI and diluted in culture medium to achieve the desired concentrations. The HCI concentration never exceeded the nontoxic dose of 100 nmoVL. DEM and D", purchased from Aldrich Chemical (Milwaukee, WI), were dissolved in serum-free medium immediately before use. .01, 2% sodium dodecyl sulfate, 50% glycerol, and 0.5% orange G), the suspensions were incubated at 65°C for 10 minutes, chilled on ice, and again centrifuged at 12,000g for 10 minutes. Equivalent volumes of supernatant containing both RNA and DNA were electrophoresed in a 1.5% agarose gel, after which RNA was digested by incubating the gel with 50 pg/mL of RNase (Ameresco, Solon, OH) in 90 mmom Tris-borate, 2 mmoVL EDTA for 3 to 4 hours. DNA was stained with ethidium bromide (0.5 pg/mL) and photographed. In general, growth inhibition, cell cycle distribution, and DNA fragmentation were all measured in the same population of drug-treated cells.
RESULTS
The effect of the FAC protein on HN2-, DMM-, and DEMinduced growth inhibition. Parental HSC536N (mutant) cells, HSC536N + pFAC3 (corrected) cells, and normal
wild-type cells were treated with various doses of mustards, and nuclei were counted 3 days later. Growth inhibition induced by HN2, DEM, and DMM is illustrated in Fig 1. The effective dose of HN2 necessary to produce a 50% reduction in cell growth (ED,,) in the mutant cells was 10 nmol/L. Overexpression of the wild-type FAC cDNA increased the HN2 EDso by 15-fold to 150 nmol/L, approaching that of the wild-type control cells. Consistent with this observation, in cells treated with 250 nmol/L HN2, overexpression of FAC increased viability determined by trypan blue exclusion by 54%, demonstrating that the FAC protein prevents cytotoxic, as well as cytostatic effects of HN2.
The ED50 values for growth inhibition induced by DMM and DEM in FA-C mutant cells were 6.10 pmol/L and 8.65 pmol/L (Fig 1) . Thus, DMM inhibits growth of these cells 610 times less effectively than does HN2, and DEM inhibits their growth 865 times less effectively. Overexpression of wild-type FAC in these cells failed to protect against monofunctional mustard-induced growth inhibition. Rather, overexpression of FAC conferred a 1.4-fold increased sensitivity, which is reflected in EDso values of 4.5 pmol/L DMM and 6.0 pmol/L DEM. Consistent with this observation, viability of the corrected cells treated with 50 pmol/L DMM or 50 pmol/L DEM determined by trypan blue exclusion was approximately 50% lower than comparably treated mutant cells. It is notable that the wild-type cells are significantly more resistant to the monofunctional mustards than both the mutant and corrected FA cells. This observation, together with the somewhat greater resistance of the wild-typ cells to the bifunctional mustard (Fig lA) , suggests that these cells are, in general, more resistant to alkylating agents than are the HSC536N cells, possibly due to a nonspecific mechanism, such as elevated thiol levels.",45
For personal use only. on October 27, 2017. by guest www.bloodjournal.org (Fig 2B) . This increase was associated with a concomitant decrease in the GO/Gl-and S-phase populations. Seventy-two hours after treatment with 250 nmol/L HN2,60% to 72% of the mutant cells were in arrested G2/M. At a higher dose (500 nmoY L), the G2/M population was reduced by approximately 20%, with a corresponding increase in the WIG1 population (data not shown), suggesting that cells were dying in G2/M. In addition, a small (-5%) population of tetraploid cells was seen only in HN2-treated mutant cells, suggesting that these cells had failed to go though mitosis. HN2-induced G2/M arrest and accumulation of tetraploid cells was essentially absent in the corrected, as well as the normal wild-type cells (Fig 2) .
Changes in cell cycle distribution of the mutant and corrected cells over time are shown in Fig 3. Neither the untreated mutant nor corrected cells arrested spontaneously in G2/M during 96 hours of log-phase growth (data not shown). Within the initial 24-hour period after treatment with 250 nmol/L HN2, the proportions of both mutant and corrected cells in S phase increased by approximately 40% (Fig 3) . Between 24 and 72 hours, the number of mutant cells in G2/ M progressively increased until approximately 72% of cells were in G2/M at 72 hours. Wright-Giemsa staining verified that most mutant cells were arrested in G2, rather than in mitosis. In contrast to the mutant cells, the corrected cells gradually recovered from the transient S-phase arrest and progressed through mitosis to the next cycle.
DMM and DEM predominately produced an S-phase accumulation in both mutant and corrected cell lines (Fig 4) . Seventy-two hours after treatment with 50 pmolL DEM, the mutant and corrected cells in S phase had increased by 35% and 38%, respectively. Although similar proportions of mutant and corrected cells were in S phase, corrected cells arrested earlier than did mutant cells. Treatment of mutant and corrected cells with 50 pmol/L DMM led to similar (34% and 28%, respectively) increases in numbers of cells in S phase. In both cell lines, S-phase accumulation was dose-dependent throughout a concentration range of 2.5 to 50 pmolL (data not shown).
FAC-mediated suppression of HN2-induced, but not DMM-or DEM-induced apoptosis.
Flow cytometry showed a population with less than diploid DNA content among mutant cells treated with HN2 (Fig 2B) and among both mutant and corrected cells treated with DMM or DEM (Fig   2301   4 ). Because such a population may represent cells undergoing apoptosis, we tested the hypothesis that wild-type FAC protein suppressed ISC-induced apoptosis. When measured at the time of maximal cell cycle arrest (72 hours after HN2 treatment), DNA fragmentation into multiples of 180-bp fragments occurred in a dose-dependent fashion only in the mutant cells (Fig 5) . This fragmentation was not detected in either wild-type or corrected cells treated with up to 250 nmol/L HN2. Similar fragmentation of genomic DNA in wild-type, mutant, and corrected cells required 100-fold higher doses of the monofunctional mustards (Fig 6) . No appreciable difference between mutant and corrected cells was apparent, while wild-type cells were somewhat less sensitive (consistent with the growth inhibition data in Fig 1) . FAC-mediated protection against HN2-, but not DEMor DMM-induced apoptosis, suggests that FAC suppresses only ISC-induced apoptosis.
DISCUSSION
We have observed that overexpression of wild-type FAC cDNA in a mutant lymphoblast cell line decreases HN2-induced inhibition of cell growth. This effect was associated with reduced HNZinduced tetraploidy, G2 arrest, and apoptosis. Neither the mutant nor corrected cells spontaneously arrested in G2, which has been reported to occur in mononuclear FA cells after stimulation with phytohemagglutinin.4" Both FA-C mutant and corrected cells were similarly and transiently arrested in S phase during the initial 24 hours after drug treatment (Fig 3) . Subsequently, the mutant cells accumulated in G2 (for up to 96 hours) and ceased to progress through mitosis. This prolonged G2 arrest was associated with DNA fragmentation characteristic of apoptosis. Overexpression of the wild-type FAC cDNA prevented the protracted G2 arrest and apoptosis. In contrast to these perturbations induced by HN2, the growth inhibition, S-phase arrest, and apoptosis produced by the monofunctional mustards DMM and DEM were similar in the mutant and corrected cells. We suggest that mutant HSC536N cells have increased sensitivity to bifunctional alkylating agents because of a greater susceptibility to 1%-induced cell cycle arrest and apoptosis. Whether this hypersensitivity to ISCinduced apoptosis is characteristic of all FA-C mutants, or is limited to the L554P mutation remains to be established. In similar studies reported recently by Kruyt et al, 47 it was found that hypersensitivity to MMC-induced apoptosis extended to FA complementation groups A, B, C, and D, suggesting that it is a general characteristic of FA.
Because FAC failed to ameliorate the cytotoxic effects of DMM and DEM (two non-cross-linking mustards), the protein appears to confer ISC-specific cytoprotection. Kruyt et a147 drew a similar conclusion from observations that FA cells were not hypersensitive to y-rays and UV light; however, the experiments we describe here are more definitive, because HN2, DMM, and DEM all predominately produce similar N7-guanine monoadducts in DNA. HN2, in addition to the monoadducts, produces bis(2-(guanin-7yl)-ethyl) methylamine- and N-(2-(3-adeninyl)ethyl)-N-(2-(7-guaniny-1 )ethyl)methylamine-DNA ISCS.~~.~' Although the reactivity of HN2 with DNA is only three and six times greater than that of DMM and DEM, respectively:' HN2 inhibited cell experiments comparing the cytotoxic and alkylating capabilgrowth 610 to 865 times, and induced apoptosis approxiity of monofunctional and bifunctional nitrogen and sulfur mately 100-fold more effectively, than did the monofuncmustards. The ability to generate DNA ISCs appears to be tional mustards. Thus, the greater potency of HN2 cannot the critical difference between HN2 and the monofunctional solely result from differential reactivities with DNA. Bodell
In light of these data, we propose that HN2 et al" and Roberts et a148 drew similar conclusions from is a more potent cytotoxic agent than the monofunctional mustard, because DNA ISCs activate apoptosis more efficiently than do monoadducts in DNA. Furthermore, the cyto- In all of the described experiments, the FAC corrected cells behaved essentially the same as the wild-type normal cells, with the qualification that the latter were generally more resistant to both monofunctional and bifunctional compounds, suggesting that they possess a nonspecific resistance mechanism, such as elevated thiols."." The comparisons For personal use only. on October 27, 2017. by guest www.bloodjournal.org From with the normal cell line, although indicative, are not as definitive as the information gained using the isogeneic HSC536N cell system.
In conclusion, we propose that the FAC protein decreases the sensitivity of HSC536N mutant cells to cell cycle arrest and apoptosis by restoring competent DNA ISC repair. This protective effect, presumably due to restoration of DNA ISC repair, could be due to indirect activation of other protein(s) that directly participate in lesion removal. Alternatively, in the presence of DNA damage, the FAC protein could prevent the untimely activation of an apoptotic cascade, thereby allowing postreplicative repair of DNA ISCs in G2.
